We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Newly Identified Immune Receptor Activates B Cells in Autoimmunity

By LabMedica International staff writers
Posted on 01 Jan 2014
Print article
Image: Biacore Sensor Chip for ligand capture (Photo courtesy of GE Healthcare).
Image: Biacore Sensor Chip for ligand capture (Photo courtesy of GE Healthcare).
A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like systemic lupus erythematosus (SLE) and multiple sclerosis.

A genetic variant present in approximately 15% of the world population can express an additional immune system receptor on their B cells, the cells that make antibodies. This additional receptor, called an Fc receptor, binds the antibodies made by B cells and plays a key role in regulating their production.

Scientists at the University of Alabama (Birmingham, AL, USA) determined the expression and functional properties of the Fc fragment of immunoglobulin gamma (IgG), Low Affinity IIc, Receptor (CD32) FcγRIIc in human B cells, by performing studies with B cells isolated from peripheral blood from genotyped healthy participants and from cell lines. DNA from 366 individuals enrolled into the four-dose vaccination groups and from 525 individuals enrolled into the three-dose vaccination group was used. Individuals were of European American or African American ancestry as determined by self-report and principal components analysis. There were 1,194 patients with SLE as participants and 1,656 controls.

Several different techniques were used including reverse transcription polymerase chain reaction (RT-PCR), immunocytochemistry, in vitro stimulation, enzyme-linked immunosorbent assay, immunoprecipitation, and immunoblots. Total ribonucleic acid (RNA) was prepared from cells using TRIzol Reagents (Invitrogen Life Technologies; Grand Island, NY, USA). The RT-PCR for Fc fragment of IgG, Low Affinity IIa, Receptor (FCGR2A), FCGR2B, and FCGR2C genes was performed using the Invitrogen Life Technologies’ SuperScript III First-Strand kit followed by PCR with gene-specific primers.

The authors found that this variant turns a gene that is normally silent into one that is expressed on B cells. This variant is shown to be a risk factor for the development of the autoimmune disease SLE. Patients with SLE have B cells that make antibodies that fight the body's own cells and tissues. Expression of this receptor likely contributes to this inappropriate antibody production by altering the balance of B cell activity. By analyzing antibody responses to vaccine, the team found higher antibody levels after vaccination in individuals with this genetic variant. This means individuals with the variant have enhanced early vaccine responses, and they show quicker antibody responses. Consequently, people with this variant mutation may have an advantage in fighting off infections.

Robert Kimberly, MD, the corresponding author of the study, said, “This new finding could play a significant role in the way companies design treatments for autoimmune diseases, in a more targeted approach. Now efforts can be made to target the individuals who will benefit from the treatments, based on the gene mutation.” The study was published on December 18, 2013, in the journal Science Translational Medicine.

Related Links:

University of Alabama
Invitrogen Life Technologies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.